je.st
news
Orexigen: Contrave Sales Recover- Expansion And Market Share Are Key Metrics
2015-12-14 19:08:12| Biotech - Topix.net
Orexigen investors were likely happy to see that sales recovered from the Thanksgiving holiday week, but the reality with this company remains the fact that sales volume is not high enough to bring in the revenue needed to excite the street. Despite leading the branded obesity pill sector, the revenue generated is simply not compelling.
Tags: share
key
sales
market
Category:Biotechnology and Pharmaceuticals